Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

A spermidine-based supplement may help hair grow longer by keeping it in the growth phase.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Women with PCOS have more severe liver disease.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.